Company Presentation • 09 Mar 2026 20:00
Company Presentation • 13 Jan 2026 01:00
Company Presentation • 14 Jan 2025 01:45
Company Presentation • 10 Dec 2025 23:00
Company Presentation • 06 Oct 2025 23:30
𝛼SK or SearchENTITY
Xenon Pharmaceuticals (XENE US)
Xenon Pharmaceuticals (XENE US)
7
Analysis
Health Care • Canada
Xenon Pharmaceuticals Inc. operates as a clinical-stage bio-pharmaceutical company. The Company discovers and develops therapeutics for human diseases including diseases caused by mutations in ion channels, and glybera, a gene therapy product for the treatment of adult patients with orphan lipid disorder lipoprotein lipase deficiency.
morex